Citation only
via OpenAlex
Do metabolic and inflammatory biomarkers vary depending on comorbidities and medications over the age of 90 years?
Hasan Öztin, Mehmet İlkin Naharcı, Hüseyin Doruk
The Journals of Gerontology Series A · 2016
Abstract
We read the study of Linda Enroth and colleagues named “The Relation of Cardiometabolic and Inflammatory Biomarkers as Mediators Between Educational Attainment and Functioning at the Age of 90 Years” in the Journal of Gerontology: Medical Sciences. The important aspect of this study is that it included elderly people over the age of 90 years. However, the authors may not have accounted for several factors, including depression, frailty, sarcopenia, comorbidities, and medications, those could influence their results in adjusted analyses. Frailty is a common syndrome in elderly people, which is defined as an increased sensitivity to extrinsic stress connected with loss of immunologic, neuromuscular, and metabolic function. A decrease in physiologic reserve with aging, the change of mobility, reduction in muscle strength, and nutritional disorders are indicators of frailty (1,2). As a matter of fact, functionality is prominently decreased in frail and sarcopenic elderly patients (3). CRP and fibrinogen are known as inflammatory markers of frailty (4). CRP, IL-6, and TNF alpha levels seem to be higher in frail people aged 85 years and older (5). Also, CRP, IL-6, and IL-1RA are associated with decline in physical function (6). In addition, CRP, IL-6, and TNF alpha could increase in depressive patients (7). Fundamentally, increased inflammation can cause depressive symptoms or depression can trigger inflammation. There is no information about chronic diseases and medications of the patients in the study. Chronic diseases increase with aging. Chu and colleagues (8) have found that 9.3% of the elderly patients have five or more chronic diseases. Chronic conditions affect inflammatory markers and cause a decrease in functionality. For example, CRP, fibrinogen, leukocytes, and TNF alpha levels increase in 7.4% of elderly patients with chronic obstructive lung disease/asthma (9). In addition, the ratio of polypharmacy is expected to be higher in advanced age. In England, 36% of patients aged 75 years and older use four and more drugs (10). Higher numbers of chronic diseases and polypharmacy could reduce functionality in this population (11). Especially, sedative hypnotics and anticholinergic drugs are related with functional disorders in elderly patients (12). If the authors could present data on comorbid situations and medications, their results would be more satisfactory.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/gerona/glw177
- Canonical
- link ↗
- Fetched
- 2026-11-16 MST
Cite this
APA
Öztin, H., Naharcı, M.�., & Doruk, H. (2016). Do metabolic and inflammatory biomarkers vary depending on comorbidities and medications over the age of 90 years?. <em>The Journals of Gerontology Series A</em>. https://doi.org/10.1093/gerona/glw177
Vancouver
Öztin H, Naharcı M�, Doruk H. Do metabolic and inflammatory biomarkers vary depending on comorbidities and medications over the age of 90 years?. The Journals of Gerontology Series A. 2016. doi:10.1093/gerona/glw177.
BibTeX
@article{hasan2016Dometa,
title = {Do metabolic and inflammatory biomarkers vary depending on comorbidities and medications over the age of 90 years?},
author = {Hasan Öztin and Mehmet İlkin Naharcı and Hüseyin Doruk},
journal = {The Journals of Gerontology Series A},
year = {2016},
doi = {10.1093/gerona/glw177},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The journal of nutrition health & aging 2024
Open access · CC-BY
Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR)
Tungs' Taichung Metroharbour Hospital 2016
Open access · US-GOV
Association Between Sarcopenia and Sarcopenic Obesity With Metabolic and Cardiovascular Risk Factors in Taiwanese Dialysis Patients
BMC Geriatrics 2018
Open access · CC-BY
Study on relationship between elderly sarcopenia and inflammatory cytokine IL-6, anti-inflammatory cytokine IL-10
Journal of the American Geriatrics Society 2008
Open access · OA
Fat and Inflammaging: A Dual Path to Unfitness in Elderly People?
Dokuz Eylul University 2023
Open access · US-GOV
Evaluation of Sarcopenia and Associated Factors in Patients With Lipedema
University of Maryland, Baltimore 2020
Open access · US-GOV